Bahrain is actively participating in the UAE's phase III clinical trials for the COVID-19 vaccine.
According to Ashish Koshy, the CEO of G42 Healthcare, Bahrain is working on enrolling and vaccinating close to 6,000 volunteers.
He clarified that this expansion enforces the ongoing collaboration between the two countries.
Speaking to ARN News, Koshy revealed that there will be more collaborations in the future.
He explained that the current trials have also shown positive results so far.


UAE condemns Houthi militia's attacks on Saudi Arabia
Thank You UAE campaign expands workplace participation
Dubai boosts public bus network with new routes, upgrades
UAE delegation visits Doha to offer condolences to Qatar’s Emir
Fire brought under control at Ajman residential tower
